R M Huff - JoVE Visualize

Showing results (11-20 of 20) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 20 results.

Nature|January 18, 1990

A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleusC L Chio, G F Hess, R S Graham, et al.

Journal of Theoretical Biology|May 22, 1990

Planning the purification process of active cDNA in expression cloning strategiesM N Brunden, R M Huff, T J Vidmar, et al.

Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1991

Pre- and postsynaptic dopaminergic activities of U-86170FR A Lahti, D L Evans, L M Figur, et al.

European Journal of Pharmacology|June 23, 1995

Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptorsJ Mierau, F J Schneider, H A Ensinger, et al.

The Journal of Biological Chemistry|April 22, 1994

D4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cellsC L Chio, R F Drong, D T Riley, et al.

Journal of Medicinal Chemistry|September 23, 2000

Thiazoloindans and thiazolobenzopyrans: a novel class of orally active central dopamine (partial) agonistsL A van Vliet, N Rodenhuis, H Wikström, et al.

Journal of Medicinal Chemistry|August 24, 2000

Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907)L A van Vliet, N Rodenhuis, D Dijkstra, et al.

Journal of Medicinal Chemistry|December 14, 2001

Dopamine D(3) receptor antagonists. 1. Synthesis and structure-activity relationships of 5,6-dimethoxy-N-alkyl- and N-alkylaryl-substituted 2-aminoindansS R Haadsma-Svensson, K A Cleek, D M Dinh, et al.

The Journal of Pharmacology and Experimental Therapeutics|December 1, 1996

Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonistK M Merchant, G S Gill, D W Harris, et al.

Journal of Medicinal Chemistry|August 24, 2000

Selective cyclooxygenase-2 inhibitors: heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agentsI K Khanna, Y Yu, R M Huff, et al.

Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 20 results.

Nature|January 18, 1990

A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleusC L Chio, G F Hess, R S Graham, et al.

Journal of Theoretical Biology|May 22, 1990

Planning the purification process of active cDNA in expression cloning strategiesM N Brunden, R M Huff, T J Vidmar, et al.

Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1991

Pre- and postsynaptic dopaminergic activities of U-86170FR A Lahti, D L Evans, L M Figur, et al.

European Journal of Pharmacology|June 23, 1995

Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptorsJ Mierau, F J Schneider, H A Ensinger, et al.

The Journal of Biological Chemistry|April 22, 1994

D4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cellsC L Chio, R F Drong, D T Riley, et al.

Journal of Medicinal Chemistry|September 23, 2000

Thiazoloindans and thiazolobenzopyrans: a novel class of orally active central dopamine (partial) agonistsL A van Vliet, N Rodenhuis, H Wikström, et al.

Journal of Medicinal Chemistry|August 24, 2000

Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907)L A van Vliet, N Rodenhuis, D Dijkstra, et al.

Journal of Medicinal Chemistry|December 14, 2001

Dopamine D(3) receptor antagonists. 1. Synthesis and structure-activity relationships of 5,6-dimethoxy-N-alkyl- and N-alkylaryl-substituted 2-aminoindansS R Haadsma-Svensson, K A Cleek, D M Dinh, et al.

The Journal of Pharmacology and Experimental Therapeutics|December 1, 1996

Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonistK M Merchant, G S Gill, D W Harris, et al.

Journal of Medicinal Chemistry|August 24, 2000

Selective cyclooxygenase-2 inhibitors: heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agentsI K Khanna, Y Yu, R M Huff, et al.

Pageof 2